Immunome, Inc. (IMNM)
21.48
+0.30
(+1.42%)
USD |
NASDAQ |
Dec 31, 16:00
21.50
+0.02
(+0.09%)
Pre-Market: 20:00
Immunome EPS Diluted (Quarterly): -0.6532 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Amphastar Pharmaceuticals, Inc. | 0.3639 |
| Relay Therapeutics, Inc. | -0.4301 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Context Therapeutics, Inc. | -0.1018 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.46M |
| Total Expenses (Quarterly) | 57.46M |
| Enterprise Value | 1.701B |
| Earnings Yield | -13.76% |
| Normalized Earnings Yield | -12.34 |